Loading…

Evonik declared force majeure on its threonine amino acid product ThreAMINO after its contract manufacturer shut down production in China due to COVID-19. The company said it cannot yet meet supply commitments and is trying to restore supply, though production levels in China remain reduced.
A supply shortage of a key feed amino acid can tighten availability and lift prices for feed formulators. Other Evonik amino acids and methionine products could face similar disruption.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.